RDHL · Redhill Biopharma Ltd ADR
United States · RS rating 11 · As of 2026-11-03
| Price | 0.42 USD |
|---|---|
| 1-day change | -5.9% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 26 / 15 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 6 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +70.3% |
| Market cap (USD) | $5.3M |